AI assistant
Sending…
OptimizeRx Corp — Director's Dealing 2019
Nov 14, 2019
33090_dirs_2019-11-14_f1878eb9-984b-4232-a9dc-fc9a435cb4c7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2019-11-13
Reporting Person: Vos Ellen O'Connor (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-13 | Common Stock | P | 600 | $9.62 | Acquired | 22154 | Direct |
More from OptimizeRx Corp
Board/Management Information
2026
Jun 5
Proxy Solicitation & Information Statement
2026
Jun 1
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Director's Dealing
2026
Feb 13
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23